PBH | Prestige Consumer Healthcare Inc. Stock Overview

(Stock Exchange: NYSE)

Day's Range	73.23 - 74.62
52 Week Range	56.34 - 75.80
Beta	0.46
Implied Volatility	35.48%
IV Rank	61.27%
Day's Volume	126,192
Average Volume	249,866
Shares Outstanding	49,557,400
Market Cap	3,654,362,676
Sector	Healthcare
Industry	Medical - Distribution
IPO Date	2005-02-10

Valuation
Profitability
Growth
Health
P/E Ratio	18.03
Forward P/E Ratio	N/A
EPS	4.09
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	570
Country	USA
Website	PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

PBH's peers: ALKS, AMPH, ANIP, COLL, EBS, EGRX, ELAN, EOLS, ESPR, EVO, HCM, INCR, IXHL, KMDA, MD, NBIX, OPTN, PAHC, SUPN, DCPH, SSIC, RGC, PCRX, DLTNF, RAMMF, CVGRF, BHHKF, SPBBF, PETQ, PRGO, PROC, RDY, TAK

*Chart delayed

Analyzing fundamentals for PBH we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is poor, Growth is on medium level and Health is strong. For more detailed analysis please see PBH Fundamentals page.

Watching at PBH technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on PBH Technicals page.